<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04577586</url>
  </required_header>
  <id_info>
    <org_study_id>Negative oral contrast PET/CT</org_study_id>
    <nct_id>NCT04577586</nct_id>
  </id_info>
  <brief_title>Negative Oral Contrast Agents Utilization in PET/CT Studies</brief_title>
  <official_title>Negative Oral Contrast Agents Utilization in PET/CT Studies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the performance of different negative oral contrast agents in bowel distension in&#xD;
      patient referred for PET/CT studies for various causes aiming for identification of ideal&#xD;
      oral contrast agent(OCA).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of gastrointestinal pathology depends on adequate bowel distention, which&#xD;
      optimizes resolution of the bowel wall and contents. Traditionally, high-attenuation oral&#xD;
      Contrast material in the form of iodine solutions or barium suspensions has been used to&#xD;
      obtain bowel distension in MDCT examinations&#xD;
&#xD;
      Traditional high-contrast oral agents like iodine solutions, and barium suspensions which due&#xD;
      to overcorrection problems in PET-CT interpretation lowers the accuracy of diagnosis.&#xD;
      Negative oral contrast agents like water, air, fat containing agents used with 12.5% corn oil&#xD;
      and polyethylene glycol has been used in radiological studies. Milk with 4% fat content has&#xD;
      also been tested out in radiological studies and found to be effective. As it is more easily&#xD;
      available, palatable, and acceptable especially, by children it needed to be tested in the&#xD;
      visualization of the GIT in the PET-CT studies compared to other negative contrast agents.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>compare the performance of different negative oral contrast agents in PET/Ct studies</measure>
    <time_frame>baseline</time_frame>
    <description>comparing the effect of different oral contrast on bowel distention</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>PET/CT</condition>
  <condition>Oral Contrast</condition>
  <arm_group>
    <arm_group_label>Water</arm_group_label>
    <description>Patients who ingested only water as an oral contrast</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Milk</arm_group_label>
    <description>Patients who ingested milk as an oral contrast</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mannitol</arm_group_label>
    <description>Patients who ingested mannitol as an oral contrast</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oral contrast</intervention_name>
    <description>negative oral contrast utilization in PET/CT studies</description>
    <arm_group_label>Mannitol</arm_group_label>
    <arm_group_label>Milk</arm_group_label>
    <arm_group_label>Water</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients in our institution who prepared for PET-CT with administration of oral&#xD;
        contrast material&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  all patients referred to our unit for PET/CT study for various causes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with GIT disease.&#xD;
&#xD;
          -  Pregnancy and lactation.&#xD;
&#xD;
          -  Severely ill patients.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nahla mostafa Bashank, Phd</last_name>
    <phone>01009466255</phone>
    <email>nahla_bashank_2006@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine</name>
      <address>
        <city>Assiut</city>
        <zip>71515</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nahla Bashank, MD</last_name>
      <phone>01009466255</phone>
      <email>nahla_bashank_2006@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Meyer SA, Gawde S. Utility of negative oral contrast (milk with 4% fat) in PET-CT studies. Indian J Nucl Med. 2012 Jul;27(3):151-5. doi: 10.4103/0972-3919.112719.</citation>
    <PMID>23919067</PMID>
  </reference>
  <reference>
    <citation>Koo CW, Shah-Patel LR, Baer JW, Frager DH. Cost-effectiveness and patient tolerance of low-attenuation oral contrast material: milk versus VoLumen. AJR Am J Roentgenol. 2008 May;190(5):1307-13. doi: 10.2214/AJR.07.3193.</citation>
    <PMID>18430848</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 30, 2020</study_first_submitted>
  <study_first_submitted_qc>September 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2020</study_first_posted>
  <last_update_submitted>September 30, 2020</last_update_submitted>
  <last_update_submitted_qc>September 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Nahla Mostafa Mahmoud Bashank</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

